Logo-bi
Original Article
Roghiyeh Pashaei-Asl ORCID, Maryam Pashaiasl, Esmaeil Ebrahimie, Maryam Lale Ataei, Maliheh Paknejad* ORCID
Bioimpacts. 2023;13(3): 191-206. doi: 10.34172/bi.2022.23813
PMCID: PMC10329748     PMID: 37431479     Scopus ID: 85171327177    
The application of hAFMSCs-CM, as a therapeutic reagent, can suppress breast cancer cells’ viabilities and induce apoptosis.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge